Patents by Inventor Aric Orbach

Aric Orbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of neurodegenerative eye disease using pridopidine
    Patent number: 11738012
    Abstract: The subject invention provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: August 29, 2023
    Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Hermann Kurt Russ, Michal Geva, Ralph Laufer, Aric Orbach
  • TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRIDOPIDINE
    Publication number: 20220062255
    Abstract: This application provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject, pharmaceutical composition and uses and applications thereof.
    Type: Application
    Filed: October 28, 2021
    Publication date: March 3, 2022
    Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Michal Geva, Hermann Kurt Russ, Ralph Laufer, Aric Orbach
  • PRIDOPIDINE FOR TREATING DRUG INDUCED DYSKINESIAS
    Publication number: 20210275512
    Abstract: The invention provides a method of treating a subject afflicted with a drug-induced movement disorder including levodopa-induced dyskinesia comprising periodically administering to the subject in need thereof an amount of pridopidine or pharmaceutically acceptable salt thereof effective to treat the subject.
    Type: Application
    Filed: May 10, 2021
    Publication date: September 9, 2021
    Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Michal GEVA, Aric Orbach, Michael Hayden
  • Pridopidine for treating drug induced dyskinesias
    Patent number: 11000519
    Abstract: The invention provides a method of treating a subject afflicted with a drug-induced movement disorder including levodopa-induced dyskinesia comprising periodically administering to the subject in need thereof an amount of pridopidine effective to treat the subject. The invention further provides a method of treating a subject at risk of developing a drug-induced movement disorder, including levodopa-induced dyskinesia. The invention also provides pharmaceutical compositions suitable for carrying out these methods and packages containing such pharmaceutical compositions.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: May 11, 2021
    Assignee: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Michal Geva, Aric Orbach, Michael Hayden
  • Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease
    Publication number: 20200121812
    Abstract: The present invention relates to new combinations of treatments for abnormal dopamine deficiency disorders, and related conditions, comprising deuterated catecholamine derivatives and catechol-O-methyltransferase (COMT) inhibitors.
    Type: Application
    Filed: August 29, 2019
    Publication date: April 23, 2020
    Inventors: Hermann Russ, Silvia A. Mandel, Aric Orbach
  • PRIDOPIDINE FOR TREATING DRUG INDUCED DYSKINESIAS
    Publication number: 20190350914
    Abstract: The invention provides a method of treating a subject afflicted with a drug-induced movement disorder including levodopa-induced dyskinesia comprising periodically administering to the subject in need thereof an amount of pridopidine effective to treat the subject. The invention further provides a method of treating a subject at risk of developing a drug-induced movement disorder, including levodopa-induced dyskinesia. The invention also provides pharmaceutical compositions suitable for carrying out these methods and packages containing such pharmaceutical compositions.
    Type: Application
    Filed: June 11, 2019
    Publication date: November 21, 2019
    Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Michal GEVA, Aric ORBACH, Michael HAYDEN
  • PRIDOPIDINE FOR TREATING DRUG INDUCED DYSKINESIAS
    Publication number: 20190231768
    Abstract: The invention provides a method of treating a subject afflicted with a drug-induced movement disorder including levodopa-induced dyskinesia comprising periodically administering to the subject in need thereof an amount of pridopidine effective to treat the subject. The invention further provides a method of treating a subject at risk of developing a drug-induced movement disorder, including levodopa-induced dyskinesia. The invention also provides pharmaceutical compositions suitable for carrying out these methods and packages containing such pharmaceutical compositions.
    Type: Application
    Filed: April 8, 2019
    Publication date: August 1, 2019
    Applicant: PRILENIA THERAPEUTICS DEVELOPMENT LTD.
    Inventors: Michal GEVA, Aric Orbach, Michael Hayden
  • TREATMENT OF NEURODEGENERATIVE EYE DISEASE USING PRODOPIDINE
    Publication number: 20190046516
    Abstract: The subject invention provides a method of treating a subject afflicted with a neurodegenerative eye disease comprising administering to the subject an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 14, 2019
    Applicant: Teva Pharmaceuticals International GmbH
    Inventors: Hermann Kurt Russ, Michal Geva, Ralph Laufer, Aric Orbach
  • Combination of Deuterated Levodopa With Carbidopa and Opicapone For The Treatment of Parkinson's Disease
    Publication number: 20170165381
    Abstract: The present invention relates to new combinations of treatments for abnormal dopamine deficiency disorders, and related conditions, comprising deuterated catecholamine derivatives and catechol-O-methyltransferase (COMT) inhibitors.
    Type: Application
    Filed: January 9, 2017
    Publication date: June 15, 2017
    Inventors: Hermann Russ, Silvia A. Mandel, Aric Orbach